Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 2018

View Archived Issues

Liquidia Technologies begins phase III study of LIQ-861

Mosedipimod receives FDA orphan drug designation for ARS

Cantex's CX-01 given FDA orphan drug status for AML

Deciphera Pharmaceuticals' INVICTUS study of DCC-2618 begins

First patient treated in phase I study of IMGN-632

Kura presents phase II results of tipifarnib in patients with CMML

AmpliPhi Biosciences reports topline results from expanded access program for AB-SA01 and AB-PA01

Asana BioSciences' ASN-002 shows efficacy in atopic dermatitis in proof-of-concept study

Audentes Therapeutics announces interim results from ASPIRO study of AT-132

Cortexyme begins phase I program for Alzheimer's disease candidate

Enrollment begins in phase II/III program for Catalyst Biosciences' marzeptacog alfa

Alovudine, a POLG inhibitor, shows promise for treating AML

Boston Pharmaceuticals obtains rights to Pierre Fabre drug candidate for atrial fibrillation

Janssen Pharmaceutica patents novel PI3Kbeta inhibitors

FDA awards fast track designation to tafenoquine for malaria

LifeArc and Suzhou Yabao Pharmaceutical divulge LRRK2 inhibitors

Shire receives FDA breakthrough therapy designation for maribavir

Takeda set to acquire TiGenix

Roche discloses new TLR8 agonists

WHO prequalifies first typhoid conjugate vaccine

BioMarin Pharmaceutical presents novel CGT inhibitors

GeneCentric and G1 Therapeutics establish research collaboration for drug response biomarkers

Novel KDM5B inhibitors described in Chrysalis patent

BriaCell updates progress of Bria-IMT trials

GeoVax collaborates with Vaxeal to expand cancer immunotherapy program

iTeos Therapeutics regains rights to EOS-200271 from Pfizer

Anti-GD2 CART approach shows promise for neuroblastoma treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...